首页> 外文期刊>Laboratory Animal Science >RAPID CARCINOGENICITY TESTING SYSTEM WITH TRANSGENIC MICE HARBORING HUMAN PROTOTYPE C-HRAS GENE
【24h】

RAPID CARCINOGENICITY TESTING SYSTEM WITH TRANSGENIC MICE HARBORING HUMAN PROTOTYPE C-HRAS GENE

机译:携带人类原型C-HRAS基因的转基因小鼠快速致癌性检测系统

获取原文
获取原文并翻译 | 示例
           

摘要

Rapid carcinogenicity tests were done with transgenic (Tg) mice human prototype c-HRAS gene, namely BALB/cByJxC57BL/6JF1-TgN(HRAS)2 or CB6F1-HRAS2 mice. The studies were conducted as the first step in the evaluation of the CB6F1-HRAS2 mouse as a model for the rapid carcinogenicity testing system. Results of short-term tests of various genotoxic carcinogens indicated that CB6F1-HRAS2 mice are more susceptible to these carcinogens than control non-Tg mice. According to the first-step evaluation studies, more rapid onset and a higher incidence of more malignant tumors can be expected with a higher probability after treatment with various genotoxic carcinogens in the CB6F1-HRAS2 mice that in control non-Tg mice. The CB6F1-HRAS2 mouse seems to be a promising candidate as an animal model for the development of a rapid carcinogenicity testing system.
机译:使用转基因(Tg)小鼠人类原型c-HRAS基因,即BALB / cByJxC57BL / 6JF1-TgN(HRAS)2或CB6F1-HRAS2小鼠,进行了快速致癌性测试。这项研究是在评估CB6F1-HRAS2小鼠(作为快速致癌性测试系统的模型)的第一步。各种遗传毒性致癌物的短期测试结果表明,与对照非Tg小鼠相比,CB6F1-HRAS2小鼠对这些致癌物更易感。根据第一步评估研究,在使用各种遗传毒性致癌物治疗CB6F1-HRAS2小鼠后,可以比预期的非Tg小鼠更快,更迅速地发生恶性肿瘤。作为开发快速致癌性测试系统的动物模型,CB6F1-HRAS2小鼠似乎是很有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号